Solvay confirmed rare-earth talks: Solvay stock gains 1.68 percent

Published on 10/09/2026 at 13:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

OneIM talks concern rare-earth assets on September 8, 2026. Solvay stock costs EUR 25.36 after EUR 24.94, plus 1.68 percent.

Key points in brief

Solvay confirmed potential OneIM talks on September 8, 2026, covering a strategic partnership for its rare-earths business.
The stock was trading at EUR 25.36 at Lang & Schwarz on October 9, 2026 at 1:03 p.m. CEST, up 1.68 percent from EUR 24.94.
First-half 2026 revenue was EUR 2.282 billion, while EBITDA reached EUR 305.0 million and net income EUR 64.0 million.
Jefferies maintained an Underperform rating with a EUR 20.00 target and forecast third-quarter 2026 EBITDA at EUR 175.0 million.

Pop-Art-Comic-Illustration von Chemikern in bunter Fabrikhalle mit Halbtonpunkten — Pop-Art-Comic-Szene mit stilisierten Chemikern in Fabrikhalle illustriert Solvay S.A. Branchenumfeld, BE0003470755 spielerisch dargestellt, Illustration mit AI erstellt.

Solvay (ISIN BE0003470755) confirmed potential talks with One Investment Management on September 8, 2026, while Solvay stock was trading at EUR 25.36 at Lang & Schwarz on October 9, 2026 at 1:03 p.m. CEST, up 1.68 percent versus the EUR 24.94 prior close. The proposed partnership concerns Solvay's rare-earths business, but the company described the discussions as exploratory.

Rare-earth talks remain exploratory

According to Globenewswire on September 8, 2026, Solvay said it was discussing a potential strategic partnership with OneIM for its rare-earths business. The release also stated that the discussions might not result in an agreement or transaction, keeping the financial outcome open.

EU Today reported on September 9, 2026, that the La Rochelle operation in France was central to the talks. The report cited a possible EUR 15.0 million to EUR 20.0 million expansion and a 2028 target for rare-earth feedstock from Brazil, but those plans remain separate from a completed transaction.

First-half figures show the pressure

Solvay reported first-half 2026 revenue of EUR 2.282 billion, EBITDA of EUR 305.0 million, an EBITDA margin of 20.00 percent, net income of EUR 64.0 million and free cash flow of EUR 15.0 million, according to Ideal Investor. The same source reported that second-quarter revenue fell 7.40 percent and that full-year guidance had been confirmed, giving the rare-earth discussions a backdrop of pressured operating performance.

What does the analyst view imply?

Jefferies kept an Underperform rating and a EUR 20.00 price target, according to MarketScreener on September 21, 2026. The bank forecast third-quarter 2026 EBITDA at EUR 175.0 million, 4.00 percent below consensus, and full-year EBITDA at EUR 760.0 million, 2.00 percent below consensus and near the lower end of Solvay's EUR 770.0 million to EUR 850.0 million outlook.

Three dated signals for Solvay

On July 29, 2026, Solvay's first-half figures included EUR 2.282 billion in revenue and EUR 305.0 million in EBITDA, according to Ideal Investor. On September 8, 2026, the company confirmed OneIM discussions over a potential rare-earths partnership, according to Globenewswire. On October 7, 2026, a participation notification page identified Solvay's 2025 underlying net sales as EUR 4.3 billion, according to FinanzNachrichten.

Upcoming reporting date

Solvay's next earnings date is November 4, 2026, according to InvestPane. That date gives investors a defined checkpoint for testing whether the company can deliver the EUR 175.0 million third-quarter EBITDA forecast cited by Jefferies.

Stock trades above prior close

Solvay stock was trading at EUR 25.36 at Lang & Schwarz on October 9, 2026 at 1:03 p.m. CEST, up 1.68 percent versus the EUR 24.94 prior close. InvestPane lists a 52-week range of EUR 23.54 to EUR 29.86 and market capitalization of EUR 2.6 billion as of October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Solvay stock.